Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Dermatitis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Dermatitis
    TopAbstracts in Dermatitis 11/23/2009 - (DGNews)
    TopAbstracts in Dermatitis 11/09/2009 - (DGNews)
    TopAbstracts in Dermatitis 10/26/2009 - (DGNews)
    TopAbstracts in Dermatitis 10/12/2009 - (DGNews)
    TopAbstracts in Dermatitis 09/28/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Dermatitis
    • Achieving Clinical Response and Improving Quality of Life With TNF-Alpha Antagonists in Patients With Psoriasis
    • A Practical Approach to Optimising Psoriasis Treatment With Anti-TNF-Alpha Monoclonal Antibodies
    • Achieving Long-Term Efficacy and Safety in Psoriasis Treatment With Anti-TNF-Alpha Agents
    • Current Perspectives in Treating Atopic Dermatitis

      Webcasts/CME archive

       Recent cases - Dermatitis
        Anaphylactic Reaction to Camomile Tea
        Severe Cutaneous Toxicity Following Treatment with Radiotherapy and Cetuximab: A Case Report
        Chronic Vulvocrural Dermatitis with Burning and Itching
        Patch Test Triggering Recurrence of Distant Dermatitis: The Flare-Up Phenomenon
        Infective Endocarditis Caused by Staphylococcus Aureus in a Patient with Atopic Dermatitis: A Case Report

        Cases archive
          




        my personal edition > dermatitis > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Ciclopirax Shampoo Safe And Effective For Seborrhoeic Dermatitis Of The Scalp: Presented at AAD

        By Alison Palkhivala

        SAN FRANCISCO, CA -- March 25, 2003 -- A shampoo containing 1% ciclopirax has demonstrated safety and efficacy for the treatment of seborrhoeic dermatitis of the scalp, according to a phase III, multi-national trial.

        Researchers, led by Sam Shuster, MD, from Framlingham, Suffolk, England, randomised 949 patients with moderate seborrhoeic dermatitis of the scalp in a 2:2:1 fashion to treatment with a 1% ciclopirax shampoo once weekly, 1% ciclopirax shampoo twice weekly or the same shampoo vehicle without the active ingredient. Dr. Shuster presented the results in a poster here on March 22nd at the 61st Annual Meeting of the American Academy of Dermatology.

        Prior to starting the study drug, patients had a two week run-in phase with a cosmetic shampoo, which was used at least twice weekly. During the study, they used approximately 5 mL of the medicated shampoo per application if their hair was above shoulder-length and about 10 mL per application if it was greater than shoulder length.

        Based on an intent-to-treat analysis, after four weeks of treatment, response rates, as assessed by global response rate using a 6-point scale and change from baseline were superior in both patient groups using the active ingredient, compared with the vehicle group (p<0.001 for both).

        Overall, 58.5% of patients using the ciclopirax shampoo responded to the medication, compared with 45.5% in the once weekly group and 31.6% in the vehicle group. A statistically greater number of patients in both active treatment groups cleared, compared with those in the vehicle group (p=0.001 for the twice a week and p=0.037 for the once a week group, compared with placebo).

        Adverse events associated with the treatment were primarily cutaneous and mild, and their prevalence was the same for the active treatment and vehicle groups.

        Based on these findings, the authors concluded that treatment with a 1% ciclopirax shampoo is a safe, effective and well-tolerated treatment for seborrhoeic dermatitis of the scalp.



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send